Adrenalectomy
8
5
6
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (8)
Robotic Adrenalectomy With Versus Without Indocyanine Green Fluorescence Imaging
Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension
Laparoscopic Versus Robotic Lateral Transabdominal Adrenalectomy
CHina Adrenal Venous saMPling InvestigatiON
Robot-assisted Adrenalectomy, Feasibility and Results
PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism
Readmission After Adrenalectomy
Adrenalectomy for Solitary Adrenal Gland Metastases